Wednesday, August 11, 2021 6:26:13 AM
GM Everyone ..
Little update about our wonderful drug , leronlimab..
Life is beautiful , so my son was deteriorating with COVID for I think close to 2 weeks.
He didn't do well on all the vitamins , ivermectin , and HCQ and zinc.
He was hospitalize last Friday , not responding at all to dexamethasone and tocilizumab.
I believe that maybe dexamethasone kept him off the ventilator for now.
Monday doctors signed Right to Try.
It must be signed by 2 independent doctors.
I spoke with my son doctor Monday that he is looking for a second one , so I wanted to sign with him , but he said no , cant be a family or even his partner .
Anyway he had someone signing it and e-mail to CYDY , I know that there where some other questions I think from cydy attorney.
This is not that easy to do this Right to Try , but I told them , no matter what you need to do , but please today , you see what stage my son is.
And they all were wonderful , they did the work and drug was send.
I learned last night that for now they send for 2 weeks treatment.
My son was injected with leronlimab at 3:40 PM yesterday. He was severe , not critical , not on ventilator , so it was done SC 700 mg..
And I explained to him that this drug take about 50 hrs to be completely absorb to blood circulation , so not to expect to soon improvement , but I remember other patients so he will be breathing most probably little better in AM I told him ..
2 hrs later he texted me , is it possible that drug is working already , I answered it is probably to soon , but I called him , and as few hrs before he had a problem talking , with very bad shortness of breath on high flow oxygen,
now he was talking much better , he said he put oxygen flow little lower because it came up to 99.
His caught felt better .. by another 2-3 hrs , so 4-5 hrs after leronlimab was injected they removed high flow oxygen and he is now on nasal cannula ..
This morning he texted that on 3 l oxygen his oxygen is 96-97 %.
This is a miracle to me , so apparently there is immediately enough of absorption to help patients within couple of hrs...
I understand that was of interest to nurses and doctors in the covid floor of this almost 3000 beds hospital.They never saw such a response to ANY APPROVED COVID drug..
I am planning to send an e-mail to Dr Woodcock today , and describe to her my son experience.
Thank you ALL for All the prayers , they are working.
And our LERONSALINE is better then anything I saw in my life.
Our results in Brazil should be very good.
So I guess , really " Sleep Well Shorts. "...yes , sleep well..:))
GLTA real longs.
And thank you All.
There is NO PLACEBO effect here,..!!!!!
Little update about our wonderful drug , leronlimab..
Life is beautiful , so my son was deteriorating with COVID for I think close to 2 weeks.
He didn't do well on all the vitamins , ivermectin , and HCQ and zinc.
He was hospitalize last Friday , not responding at all to dexamethasone and tocilizumab.
I believe that maybe dexamethasone kept him off the ventilator for now.
Monday doctors signed Right to Try.
It must be signed by 2 independent doctors.
I spoke with my son doctor Monday that he is looking for a second one , so I wanted to sign with him , but he said no , cant be a family or even his partner .
Anyway he had someone signing it and e-mail to CYDY , I know that there where some other questions I think from cydy attorney.
This is not that easy to do this Right to Try , but I told them , no matter what you need to do , but please today , you see what stage my son is.
And they all were wonderful , they did the work and drug was send.
I learned last night that for now they send for 2 weeks treatment.
My son was injected with leronlimab at 3:40 PM yesterday. He was severe , not critical , not on ventilator , so it was done SC 700 mg..
And I explained to him that this drug take about 50 hrs to be completely absorb to blood circulation , so not to expect to soon improvement , but I remember other patients so he will be breathing most probably little better in AM I told him ..
2 hrs later he texted me , is it possible that drug is working already , I answered it is probably to soon , but I called him , and as few hrs before he had a problem talking , with very bad shortness of breath on high flow oxygen,
now he was talking much better , he said he put oxygen flow little lower because it came up to 99.
His caught felt better .. by another 2-3 hrs , so 4-5 hrs after leronlimab was injected they removed high flow oxygen and he is now on nasal cannula ..
This morning he texted that on 3 l oxygen his oxygen is 96-97 %.
This is a miracle to me , so apparently there is immediately enough of absorption to help patients within couple of hrs...
I understand that was of interest to nurses and doctors in the covid floor of this almost 3000 beds hospital.They never saw such a response to ANY APPROVED COVID drug..
I am planning to send an e-mail to Dr Woodcock today , and describe to her my son experience.
Thank you ALL for All the prayers , they are working.
And our LERONSALINE is better then anything I saw in my life.
Our results in Brazil should be very good.
So I guess , really " Sleep Well Shorts. "...yes , sleep well..:))
GLTA real longs.
And thank you All.
There is NO PLACEBO effect here,..!!!!!
Recent CYDY News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
